Searched for
PHARMA MERGERS AND ACQUISITIONS
India's growth story, not AI trade reversal, will drive foreign flows: Sameer DalalIndia's economic strength, not AI's decline, will drive foreign capital inflows, according to Sameer Dalal. He believes AI's market correct...- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisitionZydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Indian pharma & healthcare sector saw $3.5 bn deals in Q3 2025: Grant Thornton BharatThe Indian pharmaceutical and healthcare sector saw robust deal activity in Q3, with 72 transactions totaling USD 3.5 billion. This surge, ...
- Sun Pharma offers to acquire 100% stake in Taro in an all-cash dealThe proposed acquisition does not include shares held by Sun Pharma and its affiliates. After the completion of the deal, Sun Pharma will h...
- Sun Pharmaceutical Industries tender offer for InSite Vision ends; to directly acquire sharesAs of the expiration of the tender offer on midnight yesterday, 104,216,642 shares of common stock of InSite had been tendered into and not...
- Pharma industry grappling with pricing, regulatory issues: SurveyBuoyant pharmaceutical industry is still struggling to deal with the challenges around pricing in the domestic market, increased regulation...
- Open to acquisitions but selective with targets: Sun PharmaSun Pharma says it is open to further acquisitions but will consider only targets "which will not require significant amount of management ...
- Not just MNCs, local cash-rich pharma companies also take to deal streetMultinational firms have been usually acquiring Indian drugmakers to expand in the country and leverage their manufacturing facilities.
- Plethico completes Natrol acquisitionPlethico Pharmaceuticals subsidiary, Nutra Acquisition has completed by tender offer the acquisition of Natrol in accordance with the merge...
Load More
